|
|
||||||||

Departments of
*
Immunology and
Surgery, Mayo Foundation, Rochester, MN 55905
Minor histocompatibility Ags (HA) play prominent roles in stimulating allograft rejection and are recognized by CTLs that mediate this process. There is limited information regarding the sequences of minor HA peptides and the diversity of minor HA-specific TCRs. In the case of the male minor HA (HY), a peptide presented by H2Db molecules has been sequenced. We have used spectratyping to study the diversities of Vß usage and ß complementarity-determining region 3 (CDR3) lengths of TCRs expressed by CTLs that infiltrate HY-disparate skin allografts during rejection. Spectratyping of RNA from second- and third-set male allografts on CD4-depleted, female recipients showed a reduction in Vß usage and ß CDR3 length diversity with prominent representation of Vß8 genes. CDR3 sequences, as a group, were characterized by net negative charges resulting from negatively charged residues at positions 56 and 1011. The effects of in vivo anti-Vß8 Ab treatment on rejection of second-set male allografts were investigated. This Ab treatment had no effect on allograft rejection time and resulted in increased Vß7 usage in recipients with complete Vß8 depletion. More interestingly, the net charges of ß CDR3s derived from Vß8-depleted recipients were altered by the inclusion of positively charged and polar residues at positions 46. These results indicate that Vß-specific T cell depletion has no effect on HY-disparate allograft survival, but it alters Vß usage and changes the characteristics of ß CDR3s that facilitate class I:peptide recognition.
This article has been cited by other articles:
![]() |
P. J. Wettstein, M. Strausbauch, and N. Borson Repertoires of T cell receptors expressed by graft-infiltrating T cells evolve during long-term recall responses to single minor histocompatibility antigens Int. Immunol., April 1, 2007; 19(4): 523 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Baron, I. McMorrow, D. H Sachs, and C. LeGuern Persistence of Dominant T Cell Clones in Accepted Solid Organ Transplants J. Immunol., October 15, 2001; 167(8): 4154 - 4160. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |